NEUROVISION PHARMA GMBH

City:

Grünwald

Country:

Germany

Published Applications:

Last publication date:

2017-11-09

Patent Grants:

Last grant date:

2022-01-04

Top Inventors for applications by NEUROVISION PHARMA GMBH

These are the the leading inventors for applications assigned to NEUROVISION PHARMA GMBH:

Markus Hossbach 2 Kulmbach, Germany
Hans-Lothar ARTH 2 Berlin, Germany
Monika Krampert 2 Bamberg, Germany

Recent patent applications by NEUROVISION PHARMA GMBH

NEUROVISION PHARMA GMBH based in Grünwald, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-11-09 ✅ Patent 11,213,541 granted on 2022-01-04

US20170319614A1

Human necessities

Antisense-oligonucleotides as inhibitors of TGF-R signaling

#2 | 2016-05-19 ✅ Patent 10,363,266 granted on 2019-07-30

US20160138029A1

Chemistry; metallurgy

Antisense-oligonucleotides as inhibitors of TGF-R signaling

Also check out NeuroVision Pharma GmbH's (Grünwald, Germany) applicant profile with 2 patent applications submitted.

AssigneeID:

369332 ⎘